These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2049043)

  • 1. The role of rIL-2 in the modulation of cellular immunity in resistance to infection.
    Kaplan G
    Behring Inst Mitt; 1991 Feb; (88):228-9. PubMed ID: 2049043
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of rIL-2 in the modulation of cellular immunity in resistance to infection.
    Kaplan G
    Immunol Lett; 1991 Oct; 30(2):199-200. PubMed ID: 1757105
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant interleukin-2 in lepromatous leprosy lesions: immunological and microbiological consequences.
    Villahermosa LG; Abalos RM; Walsh DS; Fajardo TT; Walsh GP
    Clin Exp Dermatol; 1997 May; 22(3):134-40. PubMed ID: 9425693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell unresponsiveness in lepromatous leprosy.
    Kamradt T
    J Rheumatol; 1993 May; 20(5):904-6. PubMed ID: 8336323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
    Corbeau P; Desforges S; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
    [No Abstract]   [Full Text] [Related]  

  • 7. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
    de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH
    J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity of T-cells from leprosy patients to ICRC and M. leprae antigens before and after vaccination.
    Gangal SG; Chiplunkar SV; Shinde SR; Samson PD; Deo MG
    Trop Med Parasitol; 1990 Sep; 41(3):314-6. PubMed ID: 1701562
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells bearing V beta 6 T cell receptors in the cell-mediated immune response to Mycobacterium leprae.
    Wang X; Golkar L; Uyemura K; Ohmen JD; Villahermosa LG; Fajardo TT; Cellona RV; Walsh GP; Modlin RL
    J Immunol; 1993 Dec; 151(12):7105-16. PubMed ID: 8258714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histopathological and immunological profile of a single lesion lepromatous leprosy (LLs).
    Misra RS; Ravi S; Iyengar B; Nath I
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):645-8. PubMed ID: 1802946
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immune response to recombinant interferon gamma and protein antigen LSR2.
    Nath I; Laal S; Sivasai KS; Tangri S; Murtaza A; Singh S; Wilfred D; Misra RS
    Trop Med Parasitol; 1990 Sep; 41(3):324-5. PubMed ID: 1701565
    [No Abstract]   [Full Text] [Related]  

  • 15. AP-1 is present in nuclear extracts of lymphocytes from lepromatous leprosy patients.
    Huizar-López R; Santerre A; Madrid-Marina V; Peralta-Zaragoza O; Villalobos-Arámbula A; Islas-Rodríguez A
    Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):274-7. PubMed ID: 12768929
    [No Abstract]   [Full Text] [Related]  

  • 16. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease.
    Job CK; Baskaran B; Jayakumar J; Aschhoff M
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):443-9. PubMed ID: 9465152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
    Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J
    J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
    Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
    J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin 2].
    Voĭtenok NN
    Ter Arkh; 1988; 60(5):42-6. PubMed ID: 3051488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.